Evergreen Therapeutics, Inc.
Evergreen Therapeutics, Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Not yet recruiting | Phase 1 | 2026-01-12 | NCT07327255 | |
| Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Not yet recruiting | Phase 2 | 2025-12-08 | NCT05170048 | |
| Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem | Advanced Endometrial Cancer | Not yet recruiting | Phase 2 | 2025-12-08 | NCT05106127 | |
| Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer | Advanced Endometrial Cancer | Not yet recruiting | Phase 3 | 2025-12-08 | NCT05077215 |